SEP
TECH icon

Signature Equity Partners’s Bio-Techne TECH Stock Holding History

Signature Equity Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286 Sell
4
-26
-87% -$1.4K ﹤0.01% 1482
2026
Q1 		$1.59K Hold
30
– – ﹤0.01% 1164
2025
Q4 		$1.78K Buy
+30
New +$1.82K ﹤0.01% 1246

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Signature Equity Partners's TECH Position: Q2 2026 in Review

Signature Equity Partners reduced its Bio-Techne (TECH) stake by 87% in Q2 2026, selling an estimated $1.4K and leaving 4 shares worth $286. The position accounts for ﹤0.01% of the portfolio, ranked #1482.

Signature Equity Partners first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.78K in Q4 2025. 352 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Signature Equity Partners held 4 shares of Bio-Techne worth $286 as of Q2 2026.
  • Signature Equity Partners sold 26 Bio-Techne shares in Q2 2026, an estimated $1.4K.
  • Bio-Techne made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1482 holding.
  • Signature Equity Partners first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Bio-Techne position peaked at $1.78K in Q4 2025.
  • 352 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.